Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Standard Chem & Pharm Co Ltd
TWSE:1720
Standard Chem & Pharm Co Ltd
TWSE:1720
Price:
56.1
TWD
-0.36%
Market Closed
Market Cap:
NT$11B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Standard Chem & Pharm Co Ltd
TWSE:1720
|
TW |
|
S
|
Steel Dynamics Inc
F:SD5
|
US |
|
Batliboi Ltd
BSE:522004
|
IN |
|
AAC Clyde Space AB
OTC:ACCMF
|
SE |
|
T
|
Teladoc Health Inc
SWB:4LL
|
US |
|
Mainfreight Ltd
NZX:MFT
|
NZ |
|
Catalyst Media Group PLC
LSE:CMX
|
UK |
|
S
|
Sunway Construction Group Bhd
KLSE:SUNCON
|
MY |
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is Standard Chem & Pharm Co Ltd's stock price target?
Not Available
Standard Chem & Pharm Co Ltd does not have any price targets made by Wall Street professionals.
What is the Gross Profit forecast for Standard Chem & Pharm Co Ltd?
Projected CAGR
7%
7%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 6%. The projected CAGR for the next -10 years is 7%.
What is the Pre-Tax Income forecast for Standard Chem & Pharm Co Ltd?
Projected CAGR
12%
12%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 13%. The projected CAGR for the next -10 years is 12%.
What is the Net Income forecast for Standard Chem & Pharm Co Ltd?
Projected CAGR
10%
10%
Over the last 13 years, the compound annual growth rate for Net Income has been 10%. The projected CAGR for the next -10 years is 10%.